AIG is also in discussions with the Centre to explore integrating genetic testing into public health programmes.
To equip users with a complete next generation sequencing (NGS) solution from sample to answer, global genomics leader Integrated DNA Technologies (IDT), together with Hamilton (Hamilton Company and ...
The global oncology companion diagnostics market is poised for strong expansion, with projections indicating a compound annual growth rate (CAGR) of approximately 10% through 2030. This growth is ...
Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...
Oct 21, 2025–Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, and Profluent Bio, a ...
DNA sequencing alone misses many disease dynamics. Researchers are turning to epigenomic profiling, especially the biomarker ...
MedPage Today on MSN
Add-On Multicancer Early Detection Test Promising Across Various Cancer Types
BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...
The global epigenetic antibodies market size is calculated at USD 2.70 billion in 2025 and is expected to reach around USD 12.01 billion by 2034, growing at a CAGR of 18.04% for the forecasted period.
In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human whole genome ...
Researchers at Boston Children's Hospital said they sequenced a patient's genome in 3 hours and 57 minutes, breaking a ...
By Dennis Thompson HealthDay ReporterFRIDAY, Oct. 17, 2025 (HealthDay News) — A new Guinness World Record for fastest whole ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback